July 2023 Legislative & Regulatory Briefing: Tell Congress to Pass the MVP Act of 2023; AMCP Gathers PDT Manufacturers for Product Demonstrations on Capitol Hill; AMCP’s Adam Colborn Discusses Biosimilar Interchangeability with AJMC; Register for the Inflation Reduction Act Pre-Conference Program at AMCP Nexus 2023; Catch Up on the Latest Regulatory NewsBREAKs.
From best practices in managing obesity to the latest and greatest in gene and cell therapies, guest blogger Steve Kheloussi highlights three reasons he will be attending AMCP eLearning Day.
In her latest blog, AMCP CEO Susan Cantrell recaps our inaugural workshop on the IRA, reinforcing that there is still a great deal of uncertainty as key milestones approach. Learn how AMCP is addressing concerns this landmark legislation is causing across managed care pharmacy and the larger healthcare industry.
On July 25, 2023, AMCP commented on the Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program [CMS-2434-P].
AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Justin Bioc, PharmD.
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.